Anika Therapeutics, Inc.
ANIK
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic aā¦ read more
Healthcare
Medical Devices
33 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$20.74
Price+7.55%
$1.46
1Y
Price
Market Cap
$277.496m
Small
Price/Earnings 3y Avg5y Avg
42.3x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+15.0%
EBITDA Margin+10.2%
Net Profit Margin-6.5%
Free Cash Flow Margin+15.0%
EBITDA Margin+10.2%
Net Profit Margin-6.5%
Free Cash Flow MarginRevenue
$120.654m
+6.9%
1y CAGR+0.1%
3y CAGR+1.6%
5y CAGREarnings
-$3.784m
+65.2%
1y CAGR+59.2%
3y CAGR-69.7%
5y CAGREPS
-$0.27
+64.5%
1y CAGR+58.9%
3y CAGR-69.0%
5y CAGRBook Value
$137.282m
$183.474m
Assets$46.192m
Liabilities$23.315m
DebtDebt to Assets
12.7%
8.6x
Debt to EBITDAFree Cash Flow
$562k
-87.1%
1y CAGR+89.2%
3y CAGR+33.3%
5y CAGRNo items found.
Press Releases
Statements and updates from the company